Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients
Authors:
- Eleni GavriilakiEleni Gavriilaki
- Christos DemosthenousCDChristos Demosthenous
- Paschalis EvangelidisPaschalis Evangelidis
- Zoi BousiouZBZoi Bousiou
- Ioannis BatsisIBIoannis Batsis
- Anna VardiAVAnna Vardi
- Despina MallouriDMDespina Mallouri
- Eudoxia-Evaggelia KoravouEKEudoxia-Evaggelia Koravou
- Nikolaos SpyridisNSNikolaos Spyridis
- Alkistis PanteliadouAPAlkistis Panteliadou
- Georgios KaravalakisGKGeorgios Karavalakis
- Marianna MasmanidouMMMarianna Masmanidou
Open Access
- 14 October 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11028
Abstract
Endothelial injury indices, such as Endothelial Activation and Stress Index (EASIX), modified EASIX (m-EASIX), and simplified EASIX (s-EASIX) scores, have been previously associated with chimeric antigen receptor-T (CAR-T) cell immunotherapy complications. Soluble urokinase-type plasminogen activator receptor (suPAR), growth differentiation factor-15 (GDF-15), and soluble C5b-9 (sC5b-9) have been described as markers of endothelial injury post-hematopoietic stem cell transplantation. In the current study, we examined whether suPAR, GDF-15, and sC5b-9 levels were associated with endothelial injury indices in adult CAR-T cell recipients. The levels of these markers were measured in patients before CAR-T cell infusion and in healthy individuals with immunoenzymatic methods. We studied 45 CAR-T cell recipients and 20 healthy individuals as the control group. SuPAR, GDF-15, and sC5b-9 levels were significantly higher in the patients’ group compared to the healthy control group (p < 0.001, in all comparisons). SuPAR levels at baseline were associated with the m-EASIX scores calculated at the same time point (p = 0.020), while suPAR and GDF-15 concentrations were correlated with EASIX scores at day 14 post-infusion (p < 0.001 in both comparisons). Moreover, sC5b-9 levels were correlated with the s-EASIX scores at infusion (p = 0.008) and the EASIX scores at day 14 (p = 0.005). In our study, sC5b9, suPAR, and GDF-15 levels were found to reflect endothelial injury in CAR-T cell recipients.Keywords
This publication has 46 references indexed in Scilit:
- EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapyBlood Vessels, Thrombosis & Hemostasis, 2024
- The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategiesAnnals of Hematology, 2024
- Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapyAnnals of Hematology, 2024
- Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2022
- The Role of Complement in HSCT-TMA: Basic Science to Clinical PracticeAdvances in Therapy, 2022
- Cardiovascular Effects of CAR T Cell TherapyJACC: Cardiooncology, 2020
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Neurotoxicity Associated with CD19-Targeted CAR-T Cell TherapiesCNS Drugs, 2018
- ComplementopathiesBlood Reviews, 2017
- Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapyJournal of Medical Virology, 2007